03 May Atomo says it could have helped University of Queensland with vaccine
The Australian covers our agreement with Joe Hockey’s firm Bondi Partners to help with our US launch. Read Article Here...
03 May Atomo Diagnostics (ASX:AT1) and Viatris to support HIV self test supply
An article in The Market Herald on our support for Unitaid's quest to expand access to HIV self-testing in low- and middle-income countries. Read Article Here...
03 May Atomo Diagnostics, Viatris Ink Deal With Unitaid to Expand HIV Self-Test Access
An article in 360DX on our deal, together with Viatris Inc., with UNITAID to expand access to HIV self-testing in low- and middle-income countries. Read Article Here...
03 May Is Atomo Diagnostics finally ready to take off?
MD John Kelly spoke to Alan Kohler about our point-of-care rapid tests. Read Article Here...
22 Mar Experts call for rapid antibody and antigen tests to be used in Australia
Our MD, John Kelly spoke to ABC News about the need for rapid antibody and antigen tests to be used in Australia. Read Article Here...
22 Mar Escrow: Here’s why it’s worth watching and which stocks are releasing shares soon
Stockhead lists Atomo Diagnostics as a stock to watch. Read Article Here...
22 Mar The Atomo Diagnostics (ASX:AT1) share price is popping 7% today
The Motley Fool talks about Atomo Diagnostics’ share price rise. Read Article Here...
19 Mar Harvard Universities Screening Program
Harvard has begun to welcome back a limited number of students, faculty, academic personnel, and staff to our campus as conditions allow. They have deployed several strategies—including high-frequency viral testing for all community members who are authorized to have a regular presence on campus—to help...
19 Mar MIT’s Screening Program
An effective testing program is a crucial part of minimizing the spread of the virus in a community, and testing innovations adopted by MIT are helping in-person activities to resume on campus. Read Article Here...
19 Mar University of Illinois Screening Program
An effective testing program is a crucial part of minimizing the spread of the virus in a community, and testing innovations developed by the University of Illinois Urbana-Champaign are helping in-person activities to resume on campus. Read Article Here...
19 Mar Yale Universities Screening Program
Yale’s Screening Program consists of two components: testing and contact tracing. The program was designed to reduce the risk of outbreaks on campus and in the New Haven community, based on epidemiologic models and the best available data. Free viral testing is available to all faculty,...
19 Mar USA Universities Testing Strategies
Colleges are planning a wide range of testing strategies, ranging from frequent universal testing to no campus-based testing at all. Variation of approaches raises questions about equity. Different colleges are planning a wide range of testing approaches this fall. Some are planning on twice-weekly testing of...
26 Feb While we wait for a vaccine, rapid tests could help keep life near to normal
It’s a sign of how well Australia has handled the pandemic that a single positive case in the community will make national headlines, while in many other countries thousands of people are dying from the disease every day. Our hotel quarantine system for returned travellers and...
19 Feb New study identifies top-performing point-of-care tests
Researchers at NSF International and Novateur Ventures screen rapid-detection tests for clinical sensitivity/specificity, limit of detection and time to results. Read Article Here...
11 Feb Employers sign up to rapid testing to protect workforce.
Dozens of public and private sector employers are now offering rapid testing to those without symptoms. Businesses and public sector organisations are joining a government scheme to test workers without symptoms who cannot work from home. Around 1 in 3 people have no symptoms and may be...
11 Feb Major banks worldwide have launched testing programs.
Big banks, including Deutsche Bank and Bank of America, are testing employees for before they step into the office. Some banks are offering their staff lab-based PCR tests, which are considered the most accurate way of detecting the virus, but they can cost around $US100 to...
29 Jan Atomo Diagnostics (ASX:AT1) posts 709% boost in quarterly cash receipts
The Motley Fool covers Atomo’s December quarterly report and how the company is positioning itself for growth in 2021. Read Article Here ...
29 Jan Atomo Diagnostics (ASX:AT1) ends Q2 FY21 with $24.7M in cash
The Market Herald reports on Atomo’s positive December 2020 quarterly report. Read Article Here ...
11 Nov Ausbiz: The Strawman Classic Week 3 – The double CEO special (AT1, TNT)
Our MD John Kelly sat down with Ausbiz to talk about Atomo’s strong growth, our solid progress with commercialising our rapid diagnostics tests and securing licensing deals with partners. Watch the interview here ...
04 Nov Atomo’s rapid Antigen test approved for use in Australia
Atomo was featured in a recent article by Biotech Dispatch regarding the approval of Atomo’s rapid antigen test. Read Article Here ...
04 Nov WA and Queensland Borders Start to Come Down
As WA and QLD take first steps to reopen borders, our CEO, John Kelly was asked to comment in the Australian Financial Review on how an antigen / antibody testing combo could help Australia to open up with more confidence. Read Article Here ...
29 Oct Another Atomo rapid test approved for use in Australia
Our MD, John Kelly was interviewed by Ausbiz about the approval for our rapid antigen test. Watch the Interview Here ...
29 Oct Why the Atomo (ASX:AT1) share price is flying 9% higher today
Motley Fool talks about our share price gain following the Australian approval of our rapid antigen test. Read the full article > ...
29 Oct Atomo Diagnostics (ASX:AT1) gets Australian approval for 10-minute rapid Antigen test
The Market Herald discusses the approval for our rapid antigen test. Read the full article > ...
29 Oct Atomo’s nasal swab test gets green light
This Business News Australia discusses the benefits and convenience of the 10-minute Antigen test. Read the full article > ...
02 Oct Atomo gains rights to rapid antigen test
An article by Biotech Dispatch on our expanded partnership with Access Bio to launch a rapid antigen test in Australia, New Zealand and India. Read the full article > ...
02 Oct “Game changing” deal for Aussie biotech Atomo
Our MD, John Kelly sat down with Ausbiz to discuss our rapid antigen test deal with Access Bio which will enable screening for acute infection and exposure at the same time. Watch the Video ...
30 Sep Why the Atomo (ASX:AT1) share price is moving higher today
An article by Motley Fool on our expanded a partnership with Access Bio to launch a rapid antigen test in Australia, New Zealand and India. Read the full article > ...
10 Sep Interview with Proactive Investors
Managing Director, John Kelly speaks to Proactive about the broad applications for Atomo’s rapid blood-based tests at the ASX Small and Mid-Cap Conference. [embed]https://www.youtube.com/watch?v=wl4xxnxZ198[/embed]...
09 Sep The Pandemic has opened up potentially lucrative opportunities for these Aussie microcaps
Atomo is mentioned in this Stockhead article as one of the Aussie companies involved in the efforts against the Pandemic. Read the full article > ...
- 1
- 2